MABIS
Adaptable bra with 32 electromagnetic sensors for non-invasive complementary screening of suspicious regions in breast tissue, with no ionizing radiation or compression.
Explore MABISSpin-off of Universidad Católica San Pablo · Arequipa, Peru
Electromagnetic technology at the service of health
We research, develop and bring to market non-invasive medical devices since 2019, backed by our own clinical evidence and intellectual property protection.
- TRL 6
- Maturity level
- 380+
- In clinical trials
- Under validation, pending DIGEMID
- PCT
- IP protection
- 2019
- R&D since
A laboratory that researches, develops and commercializes
Zamenis Biotech Innovation S.A.C. was born as a spin-off of Universidad Católica San Pablo to turn the campus’ radiofrequency research into real medical devices. Our work covers all three stages: applied research, product development, and commercialization with regulatory backing.
- Research
- In-house R&D since 2019, with scientific publications from the UCSP radiofrequency group on tissue classification and miniaturized UWB antennas.
- Development
- Devices at TRL 6, protected by a utility model patent and an international PCT application before INDECOPI.
- Commercialization
- B2B/B2G model with an active regulatory roadmap in Peru, Chile and Japan.
Technology portfolio
Three medical device lines
Early skin cancer detection
Near-field penetrating micro radar for dielectric-contrast analysis of the skin. Project funded by Applied Research Projects 2024-01.
View technologyGlucoWave
Information in preparation. Details on this line will be published soon.
View technologyClinical backing
Results backed by clinical evidence
0
patients in preclinical and clinical trials
0
specificity
0
sensitivity
0
comfort reported by users
Phase 2 clinical trials at AUNA clinics, in collaboration with IREN-SUR hospital.
Results from ongoing clinical trials. Device under validation, pending DIGEMID regulatory authorization.
Learn more about MABIS